Abstract
Angiopoietin-1 (Ang-1) is known to have hematoprotective effects by increasing the quiescence of hematopoietic stem cells. However, it remains to be determined if the upregulation of Ang-1 and the subsequent increase in the quiescence of hematopoietic stem cells are also involved in the dexamethasone (Dex)-mediated bone marrow protection. Here Western blotting and flow cytometric analyses demonstrate that Dex increases the levels of Ang-1 in mouse bone marrow and the quiescence of hematopoietic stem cells. Our data for the first time suggest that the increased quiescence of hematopoietic stem cells provides a novel mechanism of Dex-induced hematoprotection.
Original language | English |
---|---|
Pages (from-to) | 3509-3514 |
Number of pages | 6 |
Journal | FEBS Letters |
Volume | 582 |
Issue number | 23-24 |
DOIs | |
Publication status | Published - 2008 Oct 15 |
Keywords
- Angiopoietin-1
- Bone marrow
- Dexamethasone
- Hematopoietic stem cells
- Hematoprotection
ASJC Scopus subject areas
- Biophysics
- Structural Biology
- Biochemistry
- Molecular Biology
- Genetics
- Cell Biology